Selected Publications
Young JH, Ardura MI, Arrieta A, Bow EJ, Chandrasekar PH, Chen SC, Hammond SP, Husain S, Koo S, Laveren V, Nguyen MH, Patterson TF, So M, Thompson GR, Morrissey O, Schuster MG: Modeling Invasive Aspergillosis Risk for the
Application of ProphylaxisStrategies
Open Forum Infectious Disease in press : 2024.
Ohaly RA, Benoit ME, Schuster MG: Infectious Diseases: What you may have missed in 2022 Annals of Internal Medicine 176 (5): 701-717,2023.
Freyer CW, Carulli A, Gier S, Ganetsky A, Timlin C, Schuster M, et al: Letermovir vs high-dose valacyclovir for cytomegalovirus prophylaxis following haploidentical of mismatched unrelated donor allogeneic hematopoietic cell transplantation receiving post-transplant cyclophosphamide Leukemia and Lymphoma : 2022.
Minehart JC, Catania C, Perry L, Martin ME, Smith J, McCurdy SR, Pratz KW, Luger SM, Timlin C, Perl AE, Schuster M et al.: Incidence and predictors of Sars-Cov-2 antibody responses following COVID-19 vaccination in allogeneic stem cell transplant recipients. Blood 138 (S1)2888. 2021 138 : 2888,2021.
Kim GYG, Burns J, Freyer CW, Hamilton KW, Frey NV, Gill SI, Hexner EO, Luger SM, Mangan JK, Martin ME, McCurdy SR, Perl AE, Porter DL, Schuster MG4 Stadtmauer EA5 Loren AW.: Risk of invasive fungal infections in patients with high-risk MDS and AML receiving hypomethylating agents. American Journal of Hematology : 2020.
Schneeweiss S, Carver PL, Datta K, Galar A, Johnson MD, Letourneau AR, Marty F, Nagel J, Najdzinowicz M, Saul M, Schuster M, Shohan S, Silveira F, Varughese C, Wilck M, Weatherby L, Van Oene J, Walker AM: Long-term risk of hepatocellular carcinoma mortality in 23,220 hospitalized patients treated with micafungin or other parenteral antifungals J Antimicrob Chemother : pii: dkz39,2019.
Ganetsky A, Han, JH, Hughes ME, Babushok DV Frey NV, Gill SI, Hexner EO, Loren AW, Luger SM, Magan JM, Martin ME, Smith J, Freyer CW, Gilmar C, Schuster M, Stadtmauer EA, Porter DL: Oral vancomycin prophylaxis is highly effective in preventing Clostridium difficile infection in allogeneic hematopoietic cell transplant recipients Clin Infect Dis 68 (12): 2003-2009,2019.
Avery RK, Silveira FP, Benedict K, Cleveland AA, Kauffman CA, Schuster MG, Dubberke ER, Husain S, Paterson D, Chiller T, Pappas P: Cytomegalovirus Infections in Lung and Hematopoietic Cell Transplant Recipients in the Organ Transplant Infection Prevention and Detection Study: a Multi-Year, Multi-Center Prospective Cohort Study Transpl Infect Dis : e12877,2018.
Dubberke ER, Reske KA, Olsen MA, Bommarito K, Cleveland AA, Silveira FP, Schuster MG, Kauffman CA, Avery RK, Pappas PG, Chiller TM: Epidemiology and outcomes of Clostridium difficile infection in allogeneic hematopoietic cell and lung transplant recipients Transpl Infect Dis : e12855,2018.
Schuster MG, Cleveland AA, Dubberke ER, Kauffman CA, Avery RK, Husain S, Paterson DL, Silveira FP, Chiller TM, Bene K: Infections in Hematopoietic Cell Transplant Recipients: Results From the Organ Transplant Infection Project, a Multicenter, Prospective, Cohort Study
Open Forum Infect Dis 4 (2): ofx050,2017.
Academic Contact Information
University of Pennsylvania
Infectious Diseases Division
3 Silverstein, Suite E
3400 Spruce Street
Philadelphia,
PA
19104
Phone: 610-212-5201